Cancer Center Support Grant-P30

描述(由申请人提供)：加州大学戴维斯分校癌症中心是与劳伦斯·利弗莫尔国家实验室(LLNL)的综合项目，是加州大学戴维斯分校健康系统(加州大学戴维斯分校医学院和加州大学戴维斯医学中心)和加州大学戴维斯分校支持下的矩阵组织。位于加利福尼亚州萨克拉门托的加州大学戴维斯分校医疗中心校园内，该癌症中心的行政、临床和研究设施由P30竞争更新的首席调查员领导；2002年7月1日，癌症中心获得了第一个P30。癌症中心的186名成员来自加州大学戴维斯分校的教职员工和LLNL、美国农业部西部人类营养研究中心和加州公共卫生部的研究人员。为加州大学戴维斯分校癌症中心成员提供的同行评审资金总额为81,918,736.00美元，其中21,771,164.00美元(直接费用)由NCI提供。其他加入组织的调查人员也分别通过美国能源部、美国农业部和加利福尼亚州获得研究资金。在加州大学戴维斯分校癌症中心，研究分为六个项目：(1)分子肿瘤学，(2)比较肿瘤学，(3)癌症治疗学，(4)人口科学和健康差异，(5)前列腺癌，(6)生物医学技术。 P30[癌症中心支持拨款]的这一竞争性续签建议支持(1)高级领导，(2)计划领导，(3)发展计划，(4)管理，(5)规划和评估活动，(6)9个共享资源，包括基因组学、光学生物学、小鼠生物学、临床试验支持单位、生物统计学、临床和分子药理学、动物成像、生物谱库和组合化学，(7)方案审查和监测系统，(8)特定方案研究，以及(9)数据安全和监测。

DESCRIPTION (provided by applicant): The UC Davis Cancer Center, an integrated program with Lawrence Livermore National Labs (LLNL), is a matrix organization under the aegis of the UC Davis Health System (combining the UC Davis School of Medicine and the UC Davis Medical Center), and the University of California, Davis. Located on the campus of the UC Davis Medical Center in Sacramento, California, the cancer center's administrative, clinical and research facilities are under the leadership of the Principal Investigator of this P30 competitive renewal; an initial P30 was awarded to the Cancer Center on July 1, 2002. The Cancer Center draws its 186 members from the faculty of UC Davis and investigators at the LLNL, the USDA Western Human Nutrition Research Center and the California Department of Public Health. Peer-reviewed funding for UC Davis Cancer Center members totals $81,918,736.00 of which $21,771,164.00 (direct costs) is provided by the NCI. Investigators at the other organizations contributing membership are also provided research funding through the US Department of Energy, the US Department of Agriculture, and the State of California respectively. At the UC Davis Cancer Center, research is organized into six programs: (1) Molecular Oncology, (2) Comparative Oncology, (3) Cancer Therapeutics, (4) Population Sciences and Health Disparities, (5) Prostate Cancer, (6) Biomedical Technology. This competitive renewal for the P30 [Cancer Center Support Grant] proposes support for (1) senior leadership, (2) program leadership, (3) developmental programs, (4) administration, (5) planning and evaluation activities, (6) nine shared resources including genomics, optical biology, mouse biology, the clinical trials support unit, biostatistics, clinical and molecular pharmacology, animal imaging, biospecimen repository and combinatorial chemistry, (7) the Protocol Review and Monitoring System, (8) protocol-specific research, and (9) Data Safety and Monitoring.